Exceptional Ventures

Type

Venture Capital

Status

Active

Location

London, United Kingdom

Total investments

25

Average round size

1M

Portfolio companies

18

Rounds per year

12.50

Lead investments

1

Follow on index

0.28

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyConsumer GoodsFood and BeverageFood ProcessingHealth CareWellnessManufacturingPersonal HealthWearablesProduct Research

Investor highlights

Industry focus
HealthcareFoodtechWellness & FitnessFintechInsurtech Show 1 more
Stage focus
Seed
Geo focus
AustriaBelgiumBulgariaCroatiaCyprus Show 23 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
GBP 20000000
Fund raised date
2022-07-26

Analytics

Total investments
25
Lead investments
1
Rounds per year
12.50
Follow on index
0.28
Investments by industry
  • Biotechnology (7)
  • Manufacturing (4)
  • Health Care (4)
  • Food and Beverage (4)
  • Personal Health (4)
  • Show 32 more
Investments by region
  • United Kingdom (11)
  • Italy (1)
  • Belgium (2)
  • Switzerland (1)
  • Germany (3)
  • Show 2 more
Peak activity year
2022

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Avg. valuation at time of investment
416K
Group Appearance index
0.44

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Carol 30 May 2024 Seed 5M Lombardy, Milan, Italy
GlycanAge 01 Jan 2023 Biotechnology, Health Diagnostics, Personal Health Seed England, Newcastle upon Tyne, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.